Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-29 06:17 am Sale |
2024-12-31 | 13G | Immix Biopharma, Inc. IMMX |
HIRSCHMAN ORIN | 0 0.000% |
-1,455,000 (Position Closed) |
Filing History |
| 2024-02-07 09:18 am Purchase |
2024-02-06 | 13G | Immix Biopharma, Inc. IMMX |
HIRSCHMAN ORIN | 1,455,000 5.800% |
1,455,000 (New Position) |
Filing History |
| 2023-08-30 4:15 pm Purchase |
2023-08-21 | 13D | Immix Biopharma, Inc. IMMX |
GKCC LLC | 3,255,734 19.990% |
3,255,734 (New Position) |
Filing History |
| 2022-03-02 2:57 pm Sale |
2022-02-25 | 13G | Immix Biopharma, Inc. IMMX |
Murchinson Ltd. | 0 0.000% |
-695,600 (Position Closed) |
Filing History |
| 2022-02-11 06:22 am Sale |
2021-12-31 | 13G | Immix Biopharma, Inc. IMMX |
Altium Capital Management LLC | 122,388 1.600% |
-551,995 (-81.85%) |
Filing History |
| 2022-02-09 5:12 pm Purchase |
2021-12-31 | 13G | Immix Biopharma, Inc. IMMX |
Murchinson Ltd. | 695,600 5.280% |
695,600 (New Position) |
Filing History |
| 2021-12-27 6:06 pm Purchase |
2021-12-16 | 13G | Immix Biopharma, Inc. IMMX |
Altium Capital Management LLC | 674,383 8.200% |
674,383 (New Position) |
Filing History |